News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283),
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
On Tuesday, the Food and Drug Administration (FDA) modified its existing standards surrounding the COVID vaccine. Following ...
The updates underscore the fine line that HHS Secretary Robert F. Kennedy Jr. is walking as he tries to appease ...
George Leguen will serve his new 20-month sentence concurrently with a 14-year sentence he was already serving in a separate ...
But some insurers and employers may decide to still cover the shots regardless of the new recommendations, said Jen Kates, a ...
A case of NB.1.8.1., a new strain of COVID-19 that's been rising in frequency lately, was detected in Washington state.
The world went on lockdown, schools shifted online, and "social distancing" became our new normal. Five years have passed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback